Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients.

BACKGROUND Ischemic injury to the central nervous system causes cellular activation and disintegration, leading to release of cell-type-specific proteins into the cerebrospinal fluid (CSF). We investigated CSF concentrations of myelin basic protein (MBP), glial fibrillary astrocytic protein (GFAP), the calcium-binding protein S100B, and neuron-specific enolase (NSE) in acute ischemic stroke patients and their relation to initial stroke severity, stroke location, and long-term stroke outcome. METHODS CSF concentrations of MBP, GFAP, S100B, and NSE were assessed in 89 stroke patients on admission (mean 8.7 h after stroke onset) and in 35 controls. We evaluated the relation between CSF concentrations and (a) stroke severity (NIH Stroke Scale [NIHSS] score on admission, infarct volume), (b) stroke location, and (c) stroke outcome (modified Rankin Scale [mRS] score at month 3). RESULTS MBP concentration was significantly higher in subcortical than in cortical infarcts (median MBP, 1.18 vs 0.66 microg/L, P < 0.001). GFAP and S100B concentrations correlated with the NIHSS score on admission (GFAP, R = 0.35, P = 0.001; S100B, R = 0.29, P = 0.006), infarct volume (GFAP, R = 0.34, P = 0.001; S100B, R = 0.28, P = 0.008), and mRS score at month 3 (R = 0.42, P < 0.001 and R = 0.28, P = 0.007). Concentrations of NSE did not correlate with stroke characteristics. CONCLUSIONS MBP, GFAP, S100B, and NSE display relevant differences in cellular and subcellular origins, which are reflected in their relation to stroke characteristics. MBP is a marker for infarct location. GFAP and S100B correlate with stroke severity and outcome.

[1]  R. Anderson,et al.  High Serum S100B Levels for Trauma Patients without Head Injuries , 2001, Neurosurgery.

[2]  R. Brouns,et al.  Clinical, Biochemical and Neuroimaging Parameters after Thrombolytic Therapy Predict Long-Term Stroke Outcome , 2009, European Neurology.

[3]  F. Goodwin,et al.  Brain endolases as specific markers of neuronal and glial cells. , 1978, Science.

[4]  R. Donato,et al.  S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. , 2001, The international journal of biochemistry & cell biology.

[5]  K. Blennow,et al.  Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury , 2006, Neurology.

[6]  E. Thompson,et al.  Cerebrospinal fluid (CSF) and serum S100B: release and wash-out pattern , 2003, Brain Research Bulletin.

[7]  J. De Keyser,et al.  Use of the Barthel index and modified Rankin scale in acute stroke trials. , 1999, Stroke.

[8]  C. Wikkelsø,et al.  A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults , 1994, Journal of Neuroscience Methods.

[9]  B. Romner,et al.  Raised serum S100B levels after acute bone fractures without cerebral injury. , 2005, The Journal of trauma.

[10]  P. Deyn,et al.  Carboxypeptidase U (TAFIa) decreases the efficacy of thrombolytic therapy in ischemic stroke patients , 2009, Clinical Neurology and Neurosurgery.

[11]  V. Selaković,et al.  The increase of neuron-specific enolase in cerebrospinal fluid and plasma as a marker of neuronal damage in patients with acute brain infarction , 2005, Journal of Clinical Neuroscience.

[12]  P. Deyn,et al.  Clinical and biochemical diagnosis of small-vessel disease in acute ischemic stroke , 2009, Journal of the Neurological Sciences.

[13]  G. Donnan,et al.  Proof-of-Principle Phase II MRI Studies in Stroke: Sample Size Estimates From Dichotomous and Continuous Data , 2006, Stroke.

[14]  G. Schlaug,et al.  Effect of pre-stroke use of ACE inhibitors on ischemic stroke severity , 2005, BMC neurology.

[15]  Jin-Moo Lee,et al.  Identification of novel brain biomarkers. , 2006, Clinical chemistry.

[16]  C. Gillberg,et al.  A sensitive ELISA for glial fibrillary acidic protein: application in CSF of children , 1992, Journal of Neuroscience Methods.

[17]  K. Blennow,et al.  Cerebrospinal fluid markers for Alzheimer's disease evaluated after acute ischemic stroke. , 2000, Journal of Alzheimer's disease : JAD.

[18]  P. Deyn,et al.  Dimethylarginine Levels in Cerebrospinal Fluid of Hyperacute Ischemic Stroke Patients are Associated with Stroke Severity , 2009, Neurochemical Research.

[19]  D. Schmechel,et al.  Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. , 1987, Annual review of neuroscience.

[20]  C. Heizmann,et al.  S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). , 2004, Biochemical and biophysical research communications.

[21]  M. Schluep,et al.  Glial and axonal body fluid biomarkers are related to infarct volume, severity, and outcome. , 2008, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[22]  P. Mariën,et al.  Evaluation of lactate as a marker of metabolic stress and cause of secondary damage in acute ischemic stroke or TIA. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[23]  G. Borm,et al.  Cerebrospinal neuron‐specific enolase, S‐100 and myelin basic protein in neurological disorders , 1995, Acta neurologica Scandinavica.

[24]  M. Leite,et al.  Biological and methodological features of the measurement of S100B, a putative marker of brain injury. , 2008, Clinical biochemistry.

[25]  Y. Itoyama,et al.  Myelin basic protein demonstrated immunocytochemically in oligodendroglia prior to myelin sheath formation. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[26]  K. Haglid,et al.  Determination of S‐100 and Glial Fibrillary Acidic Protein Concentrations in Cerebrospinal Fluid After Brain Infarction , 1991, Stroke.

[27]  T. Leino,et al.  Effects of head and extracranial injuries on serum protein S100B levels in trauma patients. , 2004, The Journal of trauma.

[28]  R. Anderson,et al.  Increase in serum S100A1-B and S100BB during cardiac surgery arises from extracerebral sources. , 2001, The Annals of thoracic surgery.

[29]  A. Kleindienst,et al.  A critical analysis of the role of the neurotrophic protein S100B in acute brain injury. , 2006, Journal of neurotrauma.

[30]  P. Deyn,et al.  The complexity of neurobiological processes in acute ischemic stroke , 2009, Clinical Neurology and Neurosurgery.

[31]  K. Furie,et al.  Invited Article: Searching for oracles? , 2009, Neurology.

[32]  B. Winblad,et al.  Brain and Plasma Proteins in Spinal Fluid as Markers for Brain Damage and Severity of Stroke , 1984, Stroke.

[33]  B. Bogerts,et al.  Evidence for a wide extra-astrocytic distribution of S100B in human brain , 2007, BMC Neuroscience.